Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term dupilumab study in pediatric asthma
jRCT2041210042Completed
- Sponsor
- Sanofi
- Start
- Aug 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Open-label trial of dupilumab in asthma (3 arms), sponsored by Sanofi. Primary endpoints: Number of patients experiencing any treatment-emergent adverse event and Change from baseline in pre-bronchodilator percent predicted FEV1 at Week 12. Started Aug 2021; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2041210042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041210042.